Evidence map›Paper›PMID 32880388›Full record

ArticleClinical science (London, England : 1979)2020

Metabolomics reveals the impact of Type 2 diabetes on local muscle and vascular responses to ischemic stress.

Joshua A Beckman, Jiun-Ruey Hu, Shi Huang, Eric Farber-Eger, Quinn S Wells, Thomas J Wang, Robert E Gerszten, Jane F Ferguson

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Joshua A BeckmanDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville TN, U.S.A.
Jiun-Ruey HuDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville TN, U.S.A.
Shi HuangVanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC), Vanderbilt University Medical Center, Nashville TN, U.S.A.
Eric Farber-EgerDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville TN, U.S.A.
Quinn S WellsDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville TN, U.S.A.
Thomas J WangDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas TX, U.S.A.
Robert E GersztenDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, U.S.A.
Jane F FergusonDivision of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville TN, U.S.A.
Vanderbilt University Medical Center · USBeth Israel Deaconess Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

The Impact of Diabetes on Revascularization in BEST-CLIR01HL131977 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ADAY, AARON W., BECKMAN, JOSHUA A · 2016 to 2020
$4.0M
Virtual metabolomics as a discovery tool for novel cardiometabolic disease biologyR01HL142856 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FERGUSON, JANE F, MOSLEY, JONATHAN DAVID · 2019 to 2023
$2.7M
Determinants of alpha-aminoadipic acid (2-AAA) and relationship to diabetesR01DK117144 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FERGUSON, JANE F · 2018 to 2022
$2.5M
NHLBI NIH HHS R01 HL131977NHLBI NIH HHS R01 HL142856NIDDK NIH HHS R01 DK117144
6 · The paper itself

Abstract

objectiveType 2 diabetes mellitus (T2DM) reduces exercise capacity, but the mechanisms are incompletely understood. We probed the impact of ischemic stress on skeletal muscle metabolite signatures and T2DM-related vascular dysfunction.

methodswe recruited 38 subjects (18 healthy, 20 T2DM), placed an antecubital intravenous catheter, and performed ipsilateral brachial artery reactivity testing. Blood samples for plasma metabolite profiling were obtained at baseline and immediately upon cuff release after 5 min of ischemia. Brachial artery diameter was measured at baseline and 1 min after cuff release.

resultsas expected, flow-mediated vasodilation was attenuated in subjects with T2DM (P<0.01). We confirmed known T2DM-associated baseline differences in plasma metabolites, including homocysteine, dimethylguanidino valeric acid and β-alanine (all P<0.05). Ischemia-induced metabolite changes that differed between groups included 5-hydroxyindoleacetic acid (healthy: -27%; DM +14%), orotic acid (healthy: +5%; DM -7%), trimethylamine-N-oxide (healthy: -51%; DM +0.2%), and glyoxylic acid (healthy: +19%; DM -6%) (all P<0.05). Levels of serine, betaine, β-aminoisobutyric acid and anthranilic acid were associated with vessel diameter at baseline, but only in T2DM (all P<0.05). Metabolite responses to ischemia were significantly associated with vasodilation extent, but primarily observed in T2DM, and included enrichment in phospholipid metabolism (P<0.05).

conclusionsour study highlights impairments in muscle and vascular signaling at rest and during ischemic stress in T2DM. While metabolites change in both healthy and T2DM subjects in response to ischemia, the relationship between muscle metabolism and vascular function is modified in T2DM, suggesting that dysregulated muscle metabolism in T2DM may have direct effects on vascular function.

Indexed as

MetabolomicsBrachial ArteryCase-Control StudiesDiabetes Mellitus, Type 2Endothelium, VascularExtremitiesFemaleHumansIschemiaMaleMetabolomeMiddle AgedMuscle, SkeletalPhosphorylcholineRegional Blood FlowSignal TransductionPhosphorylcholinecardiovascular physiologyischemiametabolomicstype 2 diabetes

Identifiers

PMID32880388
PMCPMC8176641
OpenAlexW3083634566

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.